A chemotheray is exhausive for the patient and can have severe long term adverse effects. For a post-operative adjuvant chemotherapy it is therefore cruial to treat only those patients who have a elavated relapse risk and would benefit from the medication. Biomarker-research in the area of colon carcinoma and recent challenges of the molecular diagnostics sector were reported by Prof. Friess, MRI and Dr. Simon, Agendia (Amsterdam) within the m4 seminar series.
To share the expert knowledge with the future students of m4 eAcademy, the seminar war recorded. Starting 2013, the modular, extra-occupational master programmes of m4 eAcademy will provide a custom fit education for the Leading-Edge Cluster m4 - Personalized Medicine.